Cargando…
The Economic Burden of Obesity by Glycemic Stage in the United States
BACKGROUND: Electronic medical records and insurance claims data from the Geisinger Health System were examined to assess the real-world healthcare costs of being overweight or obese at different glycemic stages, including normal glycemia, pre-diabetes (PreD), and type 2 diabetes (T2D). METHODS: The...
Autores principales: | Li, Qian, Blume, Steven W., Huang, Joanna C., Hammer, Mette, Graf, Thomas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486397/ https://www.ncbi.nlm.nih.gov/pubmed/25564434 http://dx.doi.org/10.1007/s40273-014-0248-5 |
Ejemplares similares
-
Regarding “The Clinical and Economic Burden of Norovirus Gastroenteritis in the United States”
por: Do, Steven R, et al.
Publicado: (2021) -
Economic Burden of Sanfilippo Syndrome in the United States
por: Ashby, Frederick, et al.
Publicado: (2023) -
Real-World Clinical and Economic Outcomes of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Mellitus in the United States
por: Li, Qian, et al.
Publicado: (2014) -
Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States
por: Ali, Sarah Naz, et al.
Publicado: (2020) -
The economic impact of obesity in the United States
por: Hammond, Ross A, et al.
Publicado: (2010)